Sweeten the deal: Glycopolymer-based engineering to modulate autoreactive T cell responses

Simple item page
dc.contributor.authorMarkusic, David M.
dc.contributor.authorBiswas, Moanaro
dc.contributor.departmentPediatrics, School of Medicine
dc.date.accessioned2024-12-09T09:53:23Z
dc.date.available2024-12-09T09:53:23Z
dc.date.issued2023
dc.eprint.versionFinal published version
dc.identifier.citationMarkusic DM, Biswas M. Sweeten the deal: Glycopolymer-based engineering to modulate autoreactive T cell responses. Mol Ther. 2023;31(11):3119-3120. doi:10.1016/j.ymthe.2023.10.014
dc.identifier.urihttps://hdl.handle.net/1805/44823
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/j.ymthe.2023.10.014
dc.relation.journalMolecular Therapy
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectCD4-Positive T-Lymphocytes
dc.subjectClone Cells
dc.subjectLiver
dc.titleSweeten the deal: Glycopolymer-based engineering to modulate autoreactive T cell responses
dc.typeArticle
ul.alternative.fulltexthttps://pmc.ncbi.nlm.nih.gov/articles/PMC10638033/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Markusic2023Sweeten-PP.pdf
Size:
181.4 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Pediatrics Works